Sale!

ALG8 Gene Glycosylation Disorder Type 1H Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “ALG8 Gene Glycosylation Disorder Type 1H Genetic Test” is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the ALG8 gene, which are responsible for a rare condition known as Congenital Disorders of Glycosylation Type 1H (CDG-1H). This genetic disorder affects the body’s ability to properly glycosylate proteins and lipids, which are crucial for various cellular functions. Symptoms of CDG-1H can vary widely among individuals but often include developmental delay, neurological issues, and digestive problems.

The test is priced at 4400 AED and involves analyzing the patient’s DNA to identify any abnormalities in the ALG8 gene that may lead to the disorder. The process is meticulous and requires a blood sample from the patient. DNA Labs UAE employs cutting-edge genetic sequencing technologies to ensure accurate and reliable results. This test is critical for early diagnosis and management of the condition, potentially improving the quality of life for affected individuals and their families. It also offers valuable information for genetic counseling, especially for families with a history of the disorder.

Description

ALG8 Gene Glycosylation disorder type 1H Genetic Test

Components: ALG8 Gene Glycosylation disorder type 1H Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Metabolic Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for ALG8 Gene Glycosylation disorder type 1H NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Glycosylation disorder type 1H.

Test Details:

ALG8 Gene Glycosylation disorder type 1H NGS Genetic Test is a genetic test that analyzes the ALG8 gene for mutations or variations that may be associated with Glycosylation disorder type 1H. This disorder affects the glycosylation process, which is the addition of sugar molecules to proteins or lipids, leading to impaired function of various organs and systems in the body.

NGS (Next-Generation Sequencing) technology is used to analyze the ALG8 gene, which allows for the detection of various types of genetic variations, including small point mutations, insertions, deletions, and large structural changes. This comprehensive approach helps to identify specific mutations or variations in the ALG8 gene that may be causing the disorder.

The test is typically performed on a blood or saliva sample, and the results can provide valuable information for diagnosis, prognosis, and treatment planning for individuals suspected of having Glycosylation disorder type 1H. It can also be used for carrier testing in individuals with a family history of the disorder.

It is important to note that this test should be ordered and interpreted by a qualified healthcare professional, such as a geneticist or genetic counselor, who can provide appropriate counseling and guidance based on the test results.

Test Name	ALG8 Gene Glycosylation disorder type 1H Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Metabolic Disorders
Doctor	General Physician
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for ALG8 Gene Glycosylation disorder type 1H NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Glycosylation disorder type 1H
Test Details	ALG8 Gene Glycosylation disorder type 1H NGS Genetic Test is a genetic test that analyzes the ALG8 gene for mutations or variations that may be associated with Glycosylation disorder type 1H. This disorder affects the glycosylation process, which is the addition of sugar molecules to proteins or lipids, leading to impaired function of various organs and systems in the body. NGS (Next-Generation Sequencing) technology is used to analyze the ALG8 gene, which allows for the detection of various types of genetic variations, including small point mutations, insertions, deletions, and large structural changes. This comprehensive approach helps to identify specific mutations or variations in the ALG8 gene that may be causing the disorder. The test is typically performed on a blood or saliva sample, and the results can provide valuable information for diagnosis, prognosis, and treatment planning for individuals suspected of having Glycosylation disorder type 1H. It can also be used for carrier testing in individuals with a family history of the disorder. It is important to note that this test should be ordered and interpreted by a qualified healthcare professional, such as a geneticist or genetic counselor, who can provide appropriate counseling and guidance based on the test results.